Sanofi in talks with Advent to sell Zentiva generic drugs arm for 1.9 bn euros

Retrieved on: 2018-04-16 15:41:15

Tags for this article:

Business

Economy

Click the tags to see associated articles and topics

Sanofi in talks with Advent to sell Zentiva generic drugs arm for 1.9 bn euros. View article details on hiswai:

Excerpt

<div>This week, it sold some brands to <b>Charterhouse Capital Partners</b>' Cooper-Vemedia drugs manufacturing arm for 158 million euros. "Following a comprehensive review of strategic options for our generics unit in Europe, we have determined that transferring this business to Advent is the best option to ...</div>

Article found on:

View Original Article